'Rediscovered' Lymphoma Drug Helps Double Survival: Study U.S. News & World Report The drug, bendamustine, more than doubled disease progression-free survival when given along with another therapy, rituximab (Rituxan), compared to the drug cocktail that's long been used to fight indolent non-Hodgkin lymphomas. |
